Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial

NCT00208182 is registered in ClinicalTrials.gov with Creighton University as lead sponsor.

NCT NCT00208182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00208182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Monotherapy in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma: a Double-Blind, Placebo Controlled, Randomized Clinical Trial
Lead sponsor
Creighton University
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2001
Completion date
August 31, 2004
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-traumatic stress disorder